The purpose of this study is to characterize the safety and efficacy in patients with generalized anxiety disorder after short- (3 months) and long-term (6 months) use of Pregabalin (Lyrica).
Pregabalin 150-300 mg given twice a day
Lorazepam 3-4 mg given twice a day
Pregabalin 450-600 mg given twice a day
Placebo
La Plata, Buenos Aires, Argentina
Lanús, Prov. de Buenos Aires, Argentina
Buenos Aires, Argentina
Buenos Aires, Argentina
Buenos Aires, Argentina